Runx2 regulates survivin expression in prostate cancer cells.
about
Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinomaDifferential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.Metastatic bone disease: role of transcription factors and future targets.The Role of RUNX2 in Osteosarcoma Oncogenesis.Runx2-Smad signaling impacts the progression of tumor-induced bone diseaseGenome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion.Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.Molecular targets for radiation oncology in prostate cancer.The RUNX family in breast cancer: relationships with estrogen signaling.Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells.The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition.High-Throughput Screen for Inhibitors of Androgen Receptor-RUNX2 Transcriptional Regulation in Prostate Cancer.Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid CancerSOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells.Roles of RUNX in Hypoxia-Induced Responses and Angiogenesis.Transcription factor Runx2 is a regulator of epithelial-mesenchymal transition and invasion in thyroid carcinomas.MiR-135a functions as a selective killer of malignant glioma.PI3K, Erk signaling in BMP7-induced epithelial-mesenchymal transition (EMT) of PC-3 prostate cancer cells in 2- and 3-dimensional cultures.Involvement of Runx3 in the basal transcriptional activation of the mouse angiotensin II type 1 receptor-associated protein gene.Contextual effect of repression of bone morphogenetic protein activity in prostate cancer.Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.Tumor Suppressor WWOX inhibits osteosarcoma metastasis by modulating RUNX2 function.Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity.Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.PTEN Loss Promotes Intratumoral Androgen Synthesis and Tumor Microenvironment Remodeling via Aberrant Activation of RUNX2 in Castration-Resistant Prostate Cancer.Runx2, a novel regulator for goblet cell differentiation and asthma development.Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations.
P2860
Q26777988-21264DDB-40C1-413E-8E4A-711AD19F8BB8Q28535017-61394CD9-81AC-44E0-9621-FC498C006572Q33732391-358D7028-47B0-455E-93C5-6D47292B3E3AQ34217531-472BC7D2-03A6-4E25-B88E-006CCA2EEEE4Q34423871-B6B47280-DCE0-4138-AB0D-9BA3F354036EQ34898865-120FB596-2B8A-4B98-AB21-72972FC28F51Q35906122-EC37E224-A95E-4842-82E6-1506E82E9B4EQ36157012-665EC62D-9152-48DF-A0E7-0EE32CDEEDBDQ36813941-FCF95AB1-EB0C-496F-B914-7A431BEB50B2Q36967420-308B590F-C2A2-45CC-A689-A9245088E21BQ37656304-7058A37F-D830-498B-801C-63F8BE65091CQ37687744-A85B5C9C-2762-43C0-87A4-520C3B70CB32Q37744995-6D90710A-857D-4181-8F9F-A332490F40EEQ38014447-7586726E-B39C-4094-B80E-34E68830818FQ38050410-2898F458-1645-4127-960A-99F134D8975DQ38340672-6B349B23-6B4B-48A8-9475-5D292D895B04Q38712047-714E349C-AD73-4AAA-9017-41A3F960524BQ38744455-D3031FD3-C4C4-47D7-871B-AA49E6382851Q38750494-744F0B7C-4B28-4070-8D0D-6AADE8BDA7B4Q38766996-3DFD1877-B2E7-4EC6-A54E-C389D689708CQ39063028-3770B645-2819-4F11-930B-9A804E553FB3Q39181432-740CAE9D-94CB-4A96-AE58-8FB4D5F4C579Q39340986-ACCDC007-E7A9-422C-96FB-9FB2D249087BQ39433440-42639A5C-3BA1-44C2-84A3-C6338329FFD0Q39468018-5ECC8EF3-F6BD-4544-B215-CD0E25C12427Q39540857-2951140D-2F2D-465A-A724-9E19F42DF8EBQ41859712-24F26B95-71A9-4790-A55A-AF943B0E3A8DQ41881214-ABC1195D-FF69-40D8-A98C-0B69FB3A63F4Q41991686-F96F66FC-A0F2-4A3F-88F4-761C42D9BC6EQ42378493-ED9467EF-3260-4A71-B9EA-4D6B53AEE2A7Q46277870-FA4B347E-E6AA-4C09-86BB-A36C812A45B8Q47888544-0F179753-AFB3-4EA2-821D-A006283A676CQ49788391-02C4C6AD-0B76-47A8-982D-2CD3F4B28FA0Q51338556-C7F12935-7359-4544-A52A-AD2E51BC3428Q52646480-AA5D510B-6CAD-4EF0-8B0B-D079F7A6463A
P2860
Runx2 regulates survivin expression in prostate cancer cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Runx2 regulates survivin expression in prostate cancer cells.
@en
Runx2 regulates survivin expression in prostate cancer cells.
@nl
type
label
Runx2 regulates survivin expression in prostate cancer cells.
@en
Runx2 regulates survivin expression in prostate cancer cells.
@nl
prefLabel
Runx2 regulates survivin expression in prostate cancer cells.
@en
Runx2 regulates survivin expression in prostate cancer cells.
@nl
P2093
P2860
P1476
Runx2 regulates survivin expression in prostate cancer cells.
@en
P2093
Adam M Bell
Chen Zhong
Michael B Cohen
Minyoung Lim
Pradip Roy-Burman
Shangxin Yang
P2860
P2888
P304
P356
10.1038/LABINVEST.2009.128
P577
2009-11-30T00:00:00Z